← Sites
715 (USA)
USA
PI: Dr. Moreau
activated
KRI 0.0
Patients
12
Active (enrolled/consented)
0
Withdrawn
2
Serious AEs
0
Open QA findings
0
Aged data queries
0
Studies & contracts total budget 159000.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
159000 USD
Patients first 12
| Ref | Status | Consented | Study |
|---|---|---|---|
| 715-1085 | completed | 2013-02-16 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1107 | completed | 2013-02-26 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1134 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 715-1155 | withdrawn | 2013-12-13 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1207 | completed | 2012-11-18 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1225 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 715-1319 | withdrawn | 2013-02-17 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1321 | completed | 2014-02-11 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1333 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 715-1397 | completed | 2013-04-03 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1405 | completed | 2013-07-06 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 715-1407 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 15 AEs · 0 serious
No serious adverse events at this site.
QA findings 0 open
No findings recorded.
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.